"Designing Growth Strategies is in our DNA"

Pancreatic Cancer Treatment Market Size, Share & Industry Analysis, By Type (Exocrine Pancreatic Cancer, Endocrine Pancreatic Cancer), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Drug Therapy, Others), By End User (Hospitals, Specialty Clinics, Research Laboratories, Others)Others and Regional Forecast, 2021-2028

Region : Global | Report ID: FBI101989 | Status : Ongoing

 

KEY MARKET INSIGHTS

Pancreatic Cancer begins when abnormal cells in the pancreas grow and divide out of control and form a tumor. The presence of tumors prevents the normal functioning of the pancreas. The occurrence and mortality rate of pancreatic cancer is more in men than in women. Pancreatic cancer starts when the cells start growing abnormally and results in symptoms such as abdominal pain, weight loss, diarrhea, jaundice, blood clot, etc. The biggest risk factor, which leads to pancreatic cancer, is smoking. Other risk factors include pancreatitis, obesity, family history of pancreatic cancer, and older age. Treatment for pancreatic cancer depends on the stage and location of the cancer as well as on overall health and personal preferences. Treatment may include surgery, radiation, chemotherapy or a combination of these. When pancreatic cancer is advanced and these treatments aren't likely to offer a benefit, the doctor offers symptom relief (palliative care).


Key Market Driver -

Rising prevalence of cancer, increasing cigarette smokers, growing obesity rates

Key Market Restraint -

High costs and side effects related to treatment of pancreatic cancer


Rising rates in tobacco consumption, increasing cigarette smokers are likely to enhance the growth of pancreatic cancer market. Additionally, rising prevalence of cancer, increase in intake of alcohol, growing obesity rates, and growing awareness pertaining to various treatment options available are anticipating the market growth at a global level. According to GLOBOCAN 2018 estimates, pancreatic cancer is 11th most common cancer in the world and about 458,918 new cases were reported globally in 2018.


However high costs, and the side effects related to the treatment of pancreatic cancer are likely to hamper the growth of pancreatic cancer market.


Market Segmentation:


By type, the market is segmented into exocrine pancreatic cancer and endocrine pancreatic cancer. Based on treatment, the market is segmented into chemotherapy, radiation therapy, immunotherapy, targeted drug therapy, and others. Based on end users, the pancreatic cancer treatment market is segmented into hospitals, specialty clinics, research laboratories, and others.


Based on geographic standpoint, the market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.


Key Players Covered:


Some of the major companies that are present in the pancreatic cancer treatment market are Novartis AG, Eli Lilly and Company., F. Hoffmann-La Roche Ltd., PharmaCyte Biotech, Inc., CLOVIS ONCOLOGY, CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd., and other prominent players.


Among the type, exocrine pancreatic cancer segment is projected to hold a considerable share of the global pancreatic cancer treatment market during the forecast period as there is high prevalence of exocrine pancreatic cancer. According to an article published by Patient Platform Limited, 95% pancreatic cancers diagnosed in the world belong to exocrine category, thus the segment dominates the market. The endocrine type of cancers are less prevalent.


Key Insights



  • Prevalence of Pancreatic Cancer for Key Countries/Regions, 2018

  • New Product Launches in Pancreatic Cancer Treatment Market

  • Technological Advancements in Global Pancreatic Cancer Treatment Market

  • Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions


Regional Analysis:


North America is projected to dominate the global pancreatic cancer treatment market over the forecast period, followed by Europe. The dominance of this region is mainly attributed to the improved healthcare infrastructure, high adoption of pancreatic treatment procedures, and the presence of large patient population. In addition, increasing incidence of pancreatic cancer is increasing the demand for treatment options.


To gain extensive insights into the market, Request for Customization


On the other hand, Asia Pacific is expected to witness the fastest growth during the forecast period. Presence of well-established hospitals and critical care centers, expanded interest for developing novel treatment options as well as large population suffering from pancreatic cancer drive the growth of the market in Asia Pacific region. Latin America and Middle East America are also expected to have a substantial growth in the pancreatic cancer treatment market.


Segmentation


























 ATTRIBUTE


 DETAILS

By Type




  • Exocrine Pancreatic Cancer

  • Endocrine Pancreatic Cancer



By Treatment




  • Chemotherapy

  • Radiation Therapy

  • Immunotherapy

  • Targeted Drug Therapy

  • Others



By End User




  • Hospitals

  • Specialty Clinics

  • Research Laboratories

  • Others



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)



Pancreatic Cancer Treatment Industry Developments



  • In April 2019, Rexahn had an agreement with BioSense for commercialising its pancreatic cancer treatment in Greater China

  • In July 2018, Sun Pharma launches Infugem injection for treatment of pancreatic cancer in the U.S.

  • In October 2016, The European Commission approved Shire's Onivyde for the treatment of adults with metastatic adenocarcinoma of the pancreas, making it the first licensed treatment for this patient group in the EU.


Pancreatic Cancer Treatment Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Galemed
3M
Roche
Johnson
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X